These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 30566387

  • 1. Improved Modeling of Plutonium-DTPA Decorporation.
    Dumit S, Avtandilashvili M, Strom DJ, McComish SL, Tabatadze G, Tolmachev SY.
    Radiat Res; 2019 Feb; 191(2):201-210. PubMed ID: 30566387
    [Abstract] [Full Text] [Related]

  • 2. The CONRAD approach to biokinetic modeling of DTPA decorporation therapy.
    Breustedt B, Blanchardon E, Bérard P, Fritsch P, Giussani A, Lopez MA, Luciani A, Nosske D, Piechowski J, Schimmelpfeng J, Sérandour AL.
    Health Phys; 2010 Oct; 99(4):547-52. PubMed ID: 20838097
    [Abstract] [Full Text] [Related]

  • 3. Validation of a system of models for plutonium decorporation therapy.
    Dumit S, Avtandilashvili M, McComish SL, Strom DJ, Tabatadze G, Tolmachev SY.
    Radiat Environ Biophys; 2019 May; 58(2):227-235. PubMed ID: 30627772
    [Abstract] [Full Text] [Related]

  • 4. Development of a New Chelation Model: Bioassay Data Interpretation and Dose Assessment after Plutonium Intake via Wound and Treatment with DTPA.
    Dumit S, Miller G, Klumpp JA, Poudel D, Bertelli L, Waters TL.
    Health Phys; 2020 Dec; 119(6):715-732. PubMed ID: 33196524
    [Abstract] [Full Text] [Related]

  • 5. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B, Blanchardon E, Berard P, Fritsch P, Giussani A, Lopez MA, Luciani A, Nosske D, Piechowski J, Schimmelpfeng J, Sérandour AL.
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [Abstract] [Full Text] [Related]

  • 6. Developing a physiologically based approach for modeling plutonium decorporation therapy with DTPA.
    Kastl M, Giussani A, Blanchardon E, Breustedt B, Fritsch P, Hoeschen C, Lopez MA.
    Int J Radiat Biol; 2014 Nov; 90(11):1062-7. PubMed ID: 24844369
    [Abstract] [Full Text] [Related]

  • 7. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P, Sérandour AL, Grémy O, Phan G, Tsapis N, Abram MC, Renault D, Fattal E, Benech H, Deverre JR, Poncy JL.
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [Abstract] [Full Text] [Related]

  • 8. Circulatory kinetics of intravenously injected 238Pu(IV) citrate and 14C-CaNa3-DTPA in mice: comparison with rat, dog, and reference man.
    Durbin PW, Kullgren B, Schmidt CT.
    Health Phys; 1997 Feb; 72(2):222-35. PubMed ID: 9003707
    [Abstract] [Full Text] [Related]

  • 9. Plutonium-DTPA Model Application with USTUR Case 0269.
    Konzen K, Brey R, Miller S.
    Health Phys; 2016 Jan; 110(1):59-65. PubMed ID: 26606066
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo assessment of plutonium speciation and decorporation in blood and target retention tissues after a systemic contamination followed by an early treatment with DTPA.
    Sérandour AL, Grémy O, Fréchou M, Renault D, Poncy JL, Fritsch P.
    Radiat Res; 2008 Aug; 170(2):208-15. PubMed ID: 18666819
    [Abstract] [Full Text] [Related]

  • 11. Ustur Case 0846: Modeling Americium Biokinetics after Intensive Decorporation Therapy.
    Breustedt B, Avtandilashvili M, McComish SL, Tolmachev SY.
    Health Phys; 2019 Aug; 117(2):168-178. PubMed ID: 30489383
    [Abstract] [Full Text] [Related]

  • 12. Ustur whole body case 0269: demonstrating effectiveness of i.v. CA-DTPA for Pu.
    James AC, Sasser LB, Stuit DB, Glover SE, Carbaugh EH.
    Radiat Prot Dosimetry; 2007 Aug; 127(1-4):449-55. PubMed ID: 18227077
    [Abstract] [Full Text] [Related]

  • 13. Decorporation approach following rat lung contamination with a moderately soluble compound of plutonium using local and systemic Ca-DTPA combined chelation.
    Grémy O, Tsapis N, Bruel S, Renault D, Van der Meeren A.
    Radiat Res; 2012 Sep; 178(3):217-23. PubMed ID: 22799632
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
    Fritsch P, Sérandour AL, Grémy O, Phan G, Tsapis N, Fattal E, Benech H, Deverre JR, Poncy JL.
    Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
    [Abstract] [Full Text] [Related]

  • 18. Modelling DTPA therapy following Am contamination in rats.
    Kastl M, Grémy O, Lamart S, Giussani A, Li WB, Hoeschen C.
    Radiat Environ Biophys; 2023 Nov; 62(4):483-495. PubMed ID: 37831188
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.